XML 31 R21.htm IDEA: XBRL DOCUMENT

Statements of Operations - Additional Information (Tables)

9 Months Ended

Mar. 31, 2022

Statements of Operations-Additional Information

Schedule of revenues disaggregated by major product category and geographic region

Net Sales by Product Type


		Three Months						Nine Months
For the Periods Ended March 31		2022			2021			2022			2021

Animal Health
MFAs and other		$	84,330		$	78,530		$	259,812		$	238,810
Nutritional specialties			41,394			36,978			114,721			105,972
Vaccines			22,865			18,872			65,987			54,205
Total Animal Health		$	148,589		$	134,380		$	440,520		$	398,987
Mineral Nutrition			69,033			58,153			190,120			163,750
Performance Products			21,997			19,196			56,356			50,335
Total		$	239,619		$	211,729		$	686,996		$	613,072

Net Sales by Region


		Three Months						Nine Months
For the Periods Ended March 31		2022			2021			2022			2021
United States		$	146,820		$	129,370		$	412,284		$	370,446
Latin America and Canada			45,048			37,386			135,722			115,808
Europe, Middle East and Africa			29,931			27,802			90,889			84,959
Asia Pacific			17,820			17,171			48,101			41,859
Total		$	239,619		$	211,729		$	686,996		$	613,072

Schedule of additional information of statements of operations

Interest Expense and Depreciation and Amortization


		Three Months						Nine Months
For the Periods Ended March 31		2022			2021			2022			2021
Interest expense, net
Term loan		$	2,208		$	1,857		$	6,745		$	5,796
Revolving credit facility			690			938			1,936			3,017
Amortization of debt issuance costs			147			221			442			662
Other			67			65			156			191
Interest expense			3,112			3,081			9,279			9,666
Interest income			(187)			(148)			(512)			(709)
		$	2,925		$	2,933		$	8,767		$	8,957

		Three Months						Nine Months
For the Periods Ended March 31		2022			2021			2022			2021
Depreciation and amortization
Depreciation of property, plant and equipment		$	6,214		$	5,763		$	17,792		$	17,479
Amortization of intangible assets			2,231			2,155			6,508			6,563
		$	8,445		$	7,918		$	24,300		$	24,042